Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 134Precursor Cell Lymphoblastic Leukemia-Lymphoma 116Myelodysplastic Syndromes 111Leukemia, Lymphocytic, Chronic, B-Cell 102Lymphoma, Non-Hodgkin 93Hodgkin Disease 92Leukemia 86Multiple Myeloma 77Lymphoma 70Lymphoma, Mantle-Cell 67Lymphoma, Follicular 67Lymphoma, Large B-Cell, Diffuse 61Leukemia, Myelogenous, Chronic, BCR-ABL Positive 60Myeloproliferative Disorders 58Lymphoma, B-Cell, Marginal Zone 58Leukemia, Myelomonocytic, Chronic 51Congenital Abnormalities 51Burkitt Lymphoma 51Leukemia, Myeloid, Chronic-Phase 49Lymphoma, Large-Cell, Immunoblastic 46Leukemia, Myeloid, Accelerated Phase 43Hematologic Neoplasms 42Anemia, Refractory, with Excess of Blasts 40Primary Myelofibrosis 36Graft vs Host Disease 36Waldenstrom Macroglobulinemia 34Neoplasms, Plasma Cell 33Blast Crisis 33Dendritic Cell Sarcoma, Interdigitating 30Lymphoma, T-Cell, Cutaneous 29

Interventions

thymoglobulin 1Mycophenolic Acid 1Cyclosporine 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neural Tube Defects × Mycophenolic Acid × Other hematologic neoplasm × Clear all
NCT01392989 2019-05-07

Post T-plant Infusion of Allogeneic Cytokine Induced Killer (CIK) Cells as Consolidative Therapy in Myelodysplastic Syndromes/Myeloproliferative Disorders

Stanford University

Phase 2 Completed
44 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Myeloid, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neural Tube Defects

Data powered by HemOnc (CC BY 4.0) Colophon âš¡